Lee can be applied neomycin in Mycobacterium tuberculosis infection

The present invention relates to rapamycin applications may benefit the anti-Mycobacterium tuberculosis infection, the main steps, clinical first line antitubercular drugs isoniazid and rifamycin As a control, absolute concentration method may benefit TB points ADM mycobacterial activity assay results show that ADM can benefit on clinical isolates of drug resistant M. tuberculosis comprising activity, significantly better than the control line clinical drug isoniazid and rifamycin, is expected to discover Currie ADM the new use in the treatment of TB infection diseases.